메뉴 건너뛰기




Volumn 58, Issue 3, 2013, Pages 529-534

Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis

Author keywords

Autoimmune hepatitis; Infliximab; Rescue treatment

Indexed keywords

ADALIMUMAB; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN G ANTIBODY; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

EID: 84874110062     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.11.010     Document Type: Article
Times cited : (186)

References (32)
  • 4
    • 77957345684 scopus 로고    scopus 로고
    • Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis
    • M.P. Manns, M. Woynarowski, W. Kreisel, Y. Lurie, C. Rust, and E. Zuckerman Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis Gastroenterology 139 2010 1198 1206
    • (2010) Gastroenterology , vol.139 , pp. 1198-1206
    • Manns, M.P.1    Woynarowski, M.2    Kreisel, W.3    Lurie, Y.4    Rust, C.5    Zuckerman, E.6
  • 7
    • 8544229063 scopus 로고    scopus 로고
    • Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis-report of three cases
    • S. Kanzler, G. Gerken, H.P. Dienes, K.H. Meyer zum Buschenfelde, and A.W. Lohse Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis-report of three cases Z Gastroenterol 35 1997 571 578
    • (1997) Z Gastroenterol , vol.35 , pp. 571-578
    • Kanzler, S.1    Gerken, G.2    Dienes, H.P.3    Meyer Zum Buschenfelde, K.H.4    Lohse, A.W.5
  • 9
    • 34447521577 scopus 로고    scopus 로고
    • Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis
    • F.S. Larsen, B. Vainer, M. Eefsen, P.N. Bjerring, and B. Adel Hansen Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis World J Gastroenterol 13 2007 3232 3236
    • (2007) World J Gastroenterol , vol.13 , pp. 3232-3236
    • Larsen, F.S.1    Vainer, B.2    Eefsen, M.3    Bjerring, P.N.4    Adel Hansen, B.5
  • 10
    • 0035002235 scopus 로고    scopus 로고
    • Long-term management and prognosis of autoimmune hepatitis (AIH): A single center experience
    • S. Kanzler, H. Lohr, G. Gerken, P.R. Galle, and A.W. Lohse Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience Z Gastroenterol 39 2001 344 348
    • (2001) Z Gastroenterol , vol.39 , pp. 344-348
    • Kanzler, S.1    Lohr, H.2    Gerken, G.3    Galle, P.R.4    Lohse, A.W.5
  • 11
    • 78049496443 scopus 로고    scopus 로고
    • Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis
    • 1857-8
    • L. Muratori, P. Muratori, G. Lanzoni, S. Ferri, and M. Lenzi Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis Hepatology 52 2010 1857-8
    • (2010) Hepatology , vol.52
    • Muratori, L.1    Muratori, P.2    Lanzoni, G.3    Ferri, S.4    Lenzi, M.5
  • 12
    • 78649477259 scopus 로고    scopus 로고
    • TNF-alpha antagonists beyond approved indications: Stories of success and prospects for the future
    • M.P. Karampetsou, S.N. Liossis, and P.P. Sfikakis TNF-alpha antagonists beyond approved indications: stories of success and prospects for the future QJM 103 2010 917 928
    • (2010) QJM , vol.103 , pp. 917-928
    • Karampetsou, M.P.1    Liossis, S.N.2    Sfikakis, P.P.3
  • 13
    • 78650162670 scopus 로고    scopus 로고
    • Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-alpha antibody-treated patients with inflammatory bowel disease
    • F. Beigel, F. Schnitzler, R. Paul Laubender, S. Pfennig, M. Weidinger, and B. Goke Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-alpha antibody-treated patients with inflammatory bowel disease Inflamm Bowel Dis 17 2010 91 98
    • (2010) Inflamm Bowel Dis , vol.17 , pp. 91-98
    • Beigel, F.1    Schnitzler, F.2    Paul Laubender, R.3    Pfennig, S.4    Weidinger, M.5    Goke, B.6
  • 15
    • 3142588819 scopus 로고    scopus 로고
    • Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease-a possible target for infliximab treatment
    • J. Agnholt, J. Kelsen, B. Brandsborg, N.O. Jakobsen, and J.F. Dahlerup Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease-a possible target for infliximab treatment Eur J Gastroenterol Hepatol 16 2004 649 655
    • (2004) Eur J Gastroenterol Hepatol , vol.16 , pp. 649-655
    • Agnholt, J.1    Kelsen, J.2    Brandsborg, B.3    Jakobsen, N.O.4    Dahlerup, J.F.5
  • 16
    • 84865412454 scopus 로고    scopus 로고
    • Cutting edge: Suppression of GM-CSF expression in murine and human T cells by IL-27
    • A. Young, E. Linehan, E. Hams, A.C. O'Hara Hall, A. McClurg, and J.A. Johnston Cutting edge: suppression of GM-CSF expression in murine and human T cells by IL-27 J Immunol 189 2012 2079 2083
    • (2012) J Immunol , vol.189 , pp. 2079-2083
    • Young, A.1    Linehan, E.2    Hams, E.3    O'Hara Hall, A.C.4    McClurg, A.5    Johnston, J.A.6
  • 17
    • 66449083072 scopus 로고    scopus 로고
    • Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans
    • H. Bruns, C. Meinken, P. Schauenberg, G. Harter, P. Kern, and R.L. Modlin Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans J Clin Invest 119 2009 1167 1177
    • (2009) J Clin Invest , vol.119 , pp. 1167-1177
    • Bruns, H.1    Meinken, C.2    Schauenberg, P.3    Harter, G.4    Kern, P.5    Modlin, R.L.6
  • 18
    • 72049102386 scopus 로고    scopus 로고
    • A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade
    • C. Weiler-Normann, C. Wiegard, C. Schramm, and A.W. Lohse A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade Am J Gastroenterol 104 2009 2877 2878
    • (2009) Am J Gastroenterol , vol.104 , pp. 2877-2878
    • Weiler-Normann, C.1    Wiegard, C.2    Schramm, C.3    Lohse, A.W.4
  • 19
    • 0032718310 scopus 로고    scopus 로고
    • International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis
    • F. Alvarez, P.A. Berg, F.B. Bianchi, L. Bianchi, A.K. Burroughs, and E.L. Cancado International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 938
    • (1999) J Hepatol , vol.31 , pp. 929-938
    • Alvarez, F.1    Berg, P.A.2    Bianchi, F.B.3    Bianchi, L.4    Burroughs, A.K.5    Cancado, E.L.6
  • 21
    • 0021378462 scopus 로고
    • Natural history, clinical features, and treatment of autoimmune hepatitis
    • A.J. Czaja Natural history, clinical features, and treatment of autoimmune hepatitis Semin Liver Dis 4 1984 1 12
    • (1984) Semin Liver Dis , vol.4 , pp. 1-12
    • Czaja, A.J.1
  • 22
    • 77953120859 scopus 로고    scopus 로고
    • Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trials
    • M.M. Lamers, M.G. van Oijen, M. Pronk, and J.P. Drenth Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials J Hepatol 53 2010 191 198
    • (2010) J Hepatol , vol.53 , pp. 191-198
    • Lamers, M.M.1    Van Oijen, M.G.2    Pronk, M.3    Drenth, J.P.4
  • 23
    • 84860389502 scopus 로고    scopus 로고
    • Mycophenolate for the treatment of autoimmune hepatitis: Prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients
    • K. Zachou, N. Gatselis, G. Papadamou, E.I. Rigopoulou, and G.N. Dalekos Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients J Hepatol 2011
    • (2011) J Hepatol
    • Zachou, K.1    Gatselis, N.2    Papadamou, G.3    Rigopoulou, E.I.4    Dalekos, G.N.5
  • 24
    • 77958508170 scopus 로고    scopus 로고
    • Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy
    • K. Sharzehi, M.A. Huang, I.R. Schreibman, and K.A. Brown Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy Can J Gastroenterol 24 2010 588 592
    • (2010) Can J Gastroenterol , vol.24 , pp. 588-592
    • Sharzehi, K.1    Huang, M.A.2    Schreibman, I.R.3    Brown, K.A.4
  • 25
    • 84860423721 scopus 로고    scopus 로고
    • Role of mycophenolate mofetil in the treatment of autoimmune hepatitis
    • C. Schramm, and A.W. Lohse Role of mycophenolate mofetil in the treatment of autoimmune hepatitis J Hepatol 55 2011 510 511
    • (2011) J Hepatol , vol.55 , pp. 510-511
    • Schramm, C.1    Lohse, A.W.2
  • 27
    • 42049107493 scopus 로고    scopus 로고
    • Treatment of patients with severe autoimmune hepatitis
    • F.S. Larsen Treatment of patients with severe autoimmune hepatitis Minerva Gastroenterol Dietol 54 2008 57 63
    • (2008) Minerva Gastroenterol Dietol , vol.54 , pp. 57-63
    • Larsen, F.S.1
  • 28
    • 79953801792 scopus 로고    scopus 로고
    • Efficacy of biological therapies in inflammatory bowel disease: Systematic review and meta-analysis
    • [660]
    • A.C. Ford, W.J. Sandborn, K.J. Khan, S.B. Hanauer, N.J. Talley, and P. Moayyedi Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis Am J Gastroenterol 106 2011 644 659 [660]
    • (2011) Am J Gastroenterol , vol.106 , pp. 644-659
    • Ford, A.C.1    Sandborn, W.J.2    Khan, K.J.3    Hanauer, S.B.4    Talley, N.J.5    Moayyedi, P.6
  • 29
    • 78649477259 scopus 로고    scopus 로고
    • TNF-alpha antagonists beyond approved indications: Stories of success and prospects for the future
    • M.P. Karampetsou, S.N. Liossis, and P.P. Sfikakis TNF-alpha antagonists beyond approved indications: stories of success and prospects for the future QJM 103 2010 917 928
    • (2010) QJM , vol.103 , pp. 917-928
    • Karampetsou, M.P.1    Liossis, S.N.2    Sfikakis, P.P.3
  • 30
    • 3142559655 scopus 로고    scopus 로고
    • Infliximab: Mechanism of action beyond TNF-alpha neutralization in inflammatory bowel disease
    • I. Kirman, R.L. Whelan, and O.H. Nielsen Infliximab: mechanism of action beyond TNF-alpha neutralization in inflammatory bowel disease Eur J Gastroenterol Hepatol 16 2004 639 641
    • (2004) Eur J Gastroenterol Hepatol , vol.16 , pp. 639-641
    • Kirman, I.1    Whelan, R.L.2    Nielsen, O.H.3
  • 31
    • 40149099357 scopus 로고    scopus 로고
    • Bacterial infections, sepsis, and multiorgan failure in cirrhosis
    • P. Tandon, and G. Garcia-Tsao Bacterial infections, sepsis, and multiorgan failure in cirrhosis Semin Liver Dis 28 2008 26 42
    • (2008) Semin Liver Dis , vol.28 , pp. 26-42
    • Tandon, P.1    Garcia-Tsao, G.2
  • 32
    • 77950638364 scopus 로고    scopus 로고
    • Primary liver transplantation for autoimmune hepatitis: A comparative analysis of the European liver transplant registry
    • C. Schramm, M. Bubenheim, R. Adam, V. Karam, J. Buckels, and J.G. O'Grady Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European liver transplant registry Liver Transpl 16 2010 461 469
    • (2010) Liver Transpl , vol.16 , pp. 461-469
    • Schramm, C.1    Bubenheim, M.2    Adam, R.3    Karam, V.4    Buckels, J.5    O'Grady, J.G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.